NVAX:NASDAQ
Novavax Inc
$10.81
arrow_downward
-0.09%(-0.0100) 1D
$10.83
arrow_upward
+0.19% (+0.020)todayPre-market
Closed: Sep 30, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVAX...
Open
$10.85
High
$11.10
Low
$10.54
Mkt. cap
1.78B
Avg. vol.
5.82M
Volume
3.97K
52-wk high
$11.97
52-wk low
$6.20
EPS
-$1.52
Beta
2.45
Shares outstanding
164.95M
No. of employees
749
Open
$10.85
High
$11.10
Low
$10.54
Mkt. cap
1.78B
Avg. vol.
5.82M
Volume
3.97K
52-wk high
$11.97
52-wk low
$6.20
EPS
-$1.52
Beta
2.45
Shares outstanding
164.95M
No. of employees
749
News stories
From web sources and news partners
Benzinga
·
1 day ago
10 Health Care Stocks Whale Activity In Today’s Session
Profile
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria.
Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine. Wikipedia
About Novavax Inc
CEOJohn C. Jacobs
Employees749
Founded1987
HeadquartersGaithersburg, Maryland, United States
SectorBiotechnology
Websitenovavax.com